Skip to content

Clinical Effects of Photodynamic Therapy in Peri-implantitis

Clinical Effects of Mechanical Debridement with Adjunctive Photodynamic Therapy or Chlorhexidine Irrigation in patients with Peri-implantitis: a Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201021049104N1
Enrollment
26
Registered
2020-11-06
Start date
2020-11-21
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peri implantitis. Post-osseointegration biological failure of dental implant

Interventions

Intervention 1: Intervention group: Scaling and root planing and mechanical debridement of dental implants with Ti curettes+ Photodynamic therapy (810 nm diode laser,0.3W, 90s continuous and with indo
photodynamic therapy will be repeated 2 weeks later)+ chlorhexidine mouthwash. Intervention 2: Control group: Scaling and root planing and mechanical debridement of dental implants with Ti curettes+ c

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18-80 years of age Presence of at least one site with peri-implantitis (PPD= 6mm, MBL=3 mm and bleeding/suppuration on probing) At least 1 year of function in implants Screw type implants with rough surface

Exclusion criteria

Exclusion criteria: Use of antibacterial or non-steroidal anti-inflammatory drugs within 3 months prior to diagnosis Implant mobility Pregnancy or breastfeeding History of autoimmune diseases, malignancy, cardiovascular insufficiency or acute diseases of other organs History of peri-implantitis or periodontal treatment in last 6 months Uncontrolled diabetes (HbA1c > 7%) Tobacco use

Design outcomes

Primary

MeasureTime frame
Probing pocket depth(PPD). Timepoint: at baseline, 2 weeks,1,3 and 6 month after treatment. Method of measurement: plastic probe.;Clinical attachment loss(CAL). Timepoint: at baseline, 2 weeks,1,3 and 6 month after treatment. Method of measurement: plastic probe.;Papillary bleeding index(PBI). Timepoint: at baseline, 2 weeks,1,3 and 6 month after treatment. Method of measurement: Observation of papillary bleeding pattern.;Modified mombelli plaque index(mPI). Timepoint: at baseline, 2 weeks,1,3 and 6 month after treatment. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactnasrin esfahanizadeh

Islamic Azad University

n_esfahanizadeh@yahoo.com+98 21 2256 4571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026